Phase II study of third-line panitumumab rechallenge in patients with metastatic wild-type KRAS colorectal cancer who achieved a clinical benefit in response to first-line panitumumab plus chemotherapy

A. Tsuji, M. Nakamura, T. Watanabe, D. Manaka, H. Matsuoka, M. Kataoka, M. Takeuchi, W. Ichikawa, M. Fujii

研究成果: Article査読

本文言語English
ページ(範囲)v68-v69
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータスPublished - 01-06-2018

All Science Journal Classification (ASJC) codes

  • 血液学
  • 腫瘍学

引用スタイル